{
  "id": 1341,
  "text": "There was no difference in OS or RFS at three years between treatment groups.It should be noted that adverse events and morbidity were not reported.The fourth identified RCT1212 found no difference in the risk of death, disease progression or severe late complications between women who received standard brachytherapy versus radical hysterectomy after both groups had received identical external beam chemoradiotherapy.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: There was no difference in OS or RFS at three years between treatment groups.It should be noted that adverse events and morbidity were not reported.The fourth identified RCT1212 found no difference in the risk of death, disease progression or severe late complications between women who received standard brachytherapy versus radical hysterectomy after both groups had received identical external bea\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "在宫颈癌的治疗中，对于已经接受标准的外部化疗和放射治疗的患者，标准近距离治疗和根治性子宫切除术在术后三年的总生存率（OS）或无复发生存率（RFS）方面没有差异。这意味着在这些特定条件下，两种治疗方法在短期生存率和无疾病进展方面的效果相似。因此，治疗方案的选择可能更多地取决于其他因素，如患者个体情况、病情阶段、医生经验和患者偏好等，而不是术后三年内的生存率差异。 ",
  "query": "在宫颈癌治疗中，标准近距离治疗和根治性子宫切除术后，是否在术后三年内存在总生存率或无复发生存率的差异？如果有，具体有哪些影响因素？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在宫颈癌治疗中，标准近距离治疗和根治性子宫切除术后，是否在术后三年内存在总生存率或无复发生存率的差异？如果有，具体有哪些影响因素？\n\n<reference text>: There was no difference in OS or RFS at three years between treatment groups.It should be noted that adverse events and morbidity were not reported.The fourth identified RCT1212 found no difference in the risk of death, disease progression or severe late complications between women who received standard brachytherapy versus radical hysterectomy after both groups had received identical external beam chemoradiotherapy.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "在宫颈癌的治疗中，对于已经接受标准的外部化疗和放射治疗的患者，标准近距离治疗和根治性子宫切除术在术后三年的总生存率（OS）或无复发生存率（RFS）方面没有差异。这意味着在这些特定条件下，两种治疗方法在短期生存率和无疾病进展方面的效果相似。因此，治疗方案的选择可能更多地取决于其他因素，如患者个体情况、病情阶段、医生经验和患者偏好等，而不是术后三年内的生存率差异。 "
}